View in EDS HTML Full Text PDF Full Text

The Selection of Andexanet Alfa vs. 4‐Factor Prothrombin Complex Concentrate for the Treatment of Life‐Threatening Hemorrhage.

Saved in:
Bibliographic Details
Title: The Selection of Andexanet Alfa vs. 4‐Factor Prothrombin Complex Concentrate for the Treatment of Life‐Threatening Hemorrhage.
Authors: Galeano, Kira1 (AUTHOR) kirajgaleano@gmail.com, Culbreth, Rachel E.2 (AUTHOR), Brent, Jeffrey3 (AUTHOR), Amaducci, Alexandra1 (AUTHOR), Falise, Alyssa M.2 (AUTHOR), Zmuda, Anna G.4 (AUTHOR), Farrah, Rita4 (AUTHOR), Liss, David5 (AUTHOR), Goldfine, Charlotte6 (AUTHOR), Costantini, Mari2 (AUTHOR), Campleman, Sharan2 (AUTHOR), Wax, Paul2 (AUTHOR), Aldy, Kim2,7 (AUTHOR), Mircea-Catalin, Fortofoiu (AUTHOR) catalin.fortofoiu@umfcv.ro
Source: Journal of Clinical Pharmacy & Therapeutics. 9/21/2026, Vol. 2026, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:02694727
DOI:10.1155/jcpt/3950388